Each week, our Regional Roundup delivers the most important and timely life sciences news from around the region. From groundbreaking research to fundraising, new development projects, and who’s hiring — we bring you the top stories that matter most. Stay informed with a curated selection of the latest news, delivered directly to your inbox weekly.
It feels like the BioHealth Capital Region is trading in the “potential” narrative for something much more tangible: proof. This week’s news isn’t just about big dollar signs, it’s about the specific infrastructure and talent required to actually move the needle. The massive $2.5B alliance between Bora and Insilico and the state’s push into AI-GMP training aren’t just isolated headlines; they’re signals that our ecosystem is leveling up, preparing the ground for the next wave of commercialization.
But the real heartbeat of this maturity? It’s the aggressive hiring surge across clinical research roles, a trend that tells us more about the regional health than any press release. We aren’t just seeing a spike in one niche; companies are filling the entire clinical funnel.
From high-level medical directors at global pharma giants like AstraZeneca to essential operational roles at the Henry M. Jackson Foundation and clinical diagnostics firms, the demand is broad and persistent. This reflects a fundamental shift: regional companies are done guessing. They’re staffing up for execution, building the sophisticated, multi-layered teams required to bridge the gap from a promising data point to a successful regulatory filing. This is the connective tissue of our ecosystem growing in real-time.
CEL-SCI announced the launch of a global Phase 3 confirmatory trial for its Multikine immunotherapy, while Reprotech achieved a major milestone with CE Mark approval for its TMRW Vault system, signaling continued regulatory and commercial momentum in the region.
As you dig into this week’s roundup, keep an eye on three specific shifts: how M&A is favoring clinically de-risked assets, the race to lock in AI-ready manufacturing capacity, and the fierce fight for the human talent that will lead the next generation of drug development.
Financial
Tracking the capital moving through the BioHealth Capital Region — funding rounds, M&A activity, and investment trends shaping Maryland, DC, and Virginia’s life sciences companies.
TEDCO Backs BC3 Technologies’ Lifesaving Bleeding Control Tech
A spray that could buy someone precious minutes before help arrives just got a boost. TEDCO’s Builder Fund is investing $200,000 in Baltimore’s BC3 Technologies, whose FDA-cleared hemostatic wound spray is built to stop severe bleeding in the critical gap before EMS shows up. With trauma claiming over 200,000 American lives a year, CEO Wayne Grube Jr. says the funding will accelerate R&D and put the tech in reach of first responders, workplaces, and families alike. Read More >
ADC Deals: What Pharma Is Actually Buying
While antibody-drug conjugate (ADC) dealmaking remains a massive driver in pharma M&A, recent market data reveals a sharp shift from early-stage speculation to clinically de-risked assets. Big Pharma is increasingly bypassing preclinical platforms to deploy capital on late-stage candidates with proven human efficacy data and clearer regulatory paths. This trend emphasizes targeted precision, with a high premium placed on next-generation linkers and novel payloads that promise better safety profiles. Read More >
People
Who we’re buzzing about this week — the leadership moves, board appointments, and rising names shaping the region’s life sciences community.
Chris Clendening Joins Precision for Medicine to Lead Its Specialty Labs Business
Bethesda-based Precision for Medicine has named laboratory operations veteran Chris Clendening as General Manager, Labs Translational Sciences, tasking him with global operations, growth strategy, and AI integration across its specialty labs business. Clendening spent 15 years at PPD and most recently led biotechnology operations at Clario, bringing two decades of experience building central lab platforms at scale. Read More >
Sneha Saggurthi Joins Veeva Systems as Learning Strategy Consultant
She started out on the manufacturing floor wishing training programs actually made sense, now she’s building them. Maryland workforce and quality expert Sneha Saggurthi has joined Veeva’s LearnGxP team as a Learning Strategy Consultant, bringing hands-on CAR-T quality compliance experience and deep regional ties as BioBuzz’s Workforce Engagement Lead. Read More >
Martin Heitmann Joins ProcellaRX’s Ascend Ecosystem as Strategic Partner
Martin Heitmann, lead author of ISPE’s GAMP® Guide on Artificial Intelligence, has joined ProcellaRX’s Ascend Ecosystem as a strategic partner through his firm, MH Consulting & Advisory. He brings more than a decade of AI governance and digital transformation expertise to ProcellaRX’s programs, supporting GxP-regulated organizations in building stronger, more accountable AI governance frameworks. Read More >
Workforce
The hiring activity, team expansions, and talent trends driving growth across Maryland, DC, and Virginia’s life sciences and biotech employers.
BioBuzz Awarded State Grant to Launch AI-GMP Training Accelerator for Maryland’s Biotech Workforce
Backed by Governor Moore’s $1.23M Lighthouse Industries Upskilling and Reskilling Program, BioBuzz Networks, the sole life sciences awardee statewide, will train incumbent biotech workers to become in-house AI champions inside Maryland’s GMP-regulated companies. The accelerator brings together ProcellaRX, CareerBuildAI, LearnForgeAI, Enclavia.ai, and Kymanox, with REGENXBIO, Xcellon Biologics, and Kemp Proteins already on board as industry partners. Read More >
BioHub Maryland and Bowie State Complete Second Year of Immersive Biopharma Manufacturing Training
Two years and 48 students in, BioBuzz sat down with the students who trained through the program to hear about their experience, and with the team behind it to talk about their approach, and what’s next for the partnership. The BioHub Maryland–Bowie State partnership is giving students hands-on biomanufacturing experience, reshaping how they approach lab work, career planning, and the life sciences job market , and helping close a real gap in Maryland’s biotech workforce. With more than 2,700 life sciences companies and 54,000 workers in the BioHealth Capital Region, the demand is real. Read More >
Who’s hiring?!
The Henry M Jackson Foundation for the Advancement of Military Medicine (HJF)
With a mission to advance military medicine so people everywhere can lead safer, healthier lives, HJF’s team members are among the brightest and most passionate minds in the field, playing an integral role in hundreds of cutting-edge research projects and programs that benefit both military and civilian communities.
They are currently hiring across 120+ roles — spanning Program, Clinical, Research, Education, Psych/Social Work, and IT functions. Apply Here >
Other employers and available roles we’re paying attention to this week:
- LGC Clinical Diagnostics (Gaithersburg, MD) is hiring a Research Associate II | Apply Now >
- Pharmaron (Baltimore, MD) is hiring an Outpatient Services Coordinator I, Clinical Research | Apply Now >
- Meso Scale Discovery (Rockville, MD) is hiring a Senior Data Engineer, Computational Sciences | Apply Now >
- AstraZeneca (Gaithersburg, MD) is hiring a Global Clinical Development Medical Director, Vaccines/Oncology | Apply Now >
Clinical + Commercial
The latest clinical trial progress, regulatory milestones, and commercial launches from companies advancing science from the lab to the market across the BioHealth Capital Region.
CEL-SCI to Launch FDA Registration-Enabling Phase 3 Confirmatory Study to Bring Multikine® to Market for Newly Diagnosed Head and Neck Cancer
CEL-SCI Corporation is launching a global Phase 3 confirmatory trial for its pre-surgical immunotherapy, Multikine, targeting newly diagnosed head and neck cancer. The study zeroes in on a specific low-PD-L1, lymph-node-negative patient population where previous trial data demonstrated an exceptional 73% five-year survival rate compared to 45% with standard care alone. The company plans to leverage early pre-surgical tumor responses to seek accelerated FDA approval. Read more >
TMRW Vault® Receives CE Mark Under the European Medical Device Regulation (MDR)
Reprotech announced that its TMRW Vault has received CE Mark approval as a Class IIa medical device, paving the way for commercialization across the European Union. The automated cryogenic system modernizes fertility clinic workflows by combining advanced onsite storage tanks with RFID-enabled CryoBeacons and ivfOS software to eliminate manual tracking errors. This regulatory milestone follows Reprotech’s business combination with TMRW Life Sciences, drastically scaling automated digital chain-of-custody solutions for frozen eggs and embryos globally. Read More >
Ecosystem
The partnerships, programs, and policy moves building the BioHealth Capital Region’s life sciences infrastructure — and the organizations driving it forward.
Maryland’s AI Biomanufacturing Ecosystem Gains Momentum
A new $2.5 billion alliance between Bora Pharmaceuticals and Insilico Medicine underscores Maryland’s growing role in the future of AI-enabled biomanufacturing. Bora’s newly acquired Rockville facility brings AI-ready manufacturing infrastructure to the BioHealth Capital Region, while state-backed workforce initiatives are building the talent needed to support the next generation of AI-powered GMP operations. Together, these investments reinforce Maryland’s position as an emerging hub where innovation, manufacturing, and workforce development. Read More >
Organotics Joins Maryland’s Life Sciences Ecosystem to Advance Neurological Drug Discovery
With its official launch, Organotics joins the growing community of life science innovators across Maryland working to advance the future of medicine. The Johns Hopkins spinout’s AI-powered platform combines advanced human brain organoids with artificial intelligence and computational genomics to improve how therapies for neurological and psychiatric disorders are discovered. They plan to grow its Maryland footprint and create local jobs, while pursuing partnerships with pharmaceutical companies, research institutions, and government organizations throughout the BioHealth Capital Region. Read More >
Other [Good] Reads
Editor’s picks from across the web — the stories, videos, and podcasts shaping the conversation in DMV biotech and life sciences this week.
Maryland Expands Enterprise Zones to Drive Economic Growth
Governor Wes Moore has announced the expansion and redesignation of Enterprise Zones across Maryland, bringing renewed tax incentives to encourage business investment, job creation, and redevelopment in key communities. The move is designed to help attract employers, support local economies, and strengthen the state’s long-term competitiveness. Read More >
Virginia Strengthens Local Life Sciences Innovation Hubs
Across Virginia, regional life sciences ecosystems are helping innovators move discoveries closer to market by connecting researchers with the funding, infrastructure, partnerships, and commercialization resources they need to grow. The effort highlights how strong local networks can accelerate innovation while strengthening the state’s life sciences economy. Read More >
How Maryland’s ecosystems are helping people live longer, healthier lives
Maryland’s “longevity economy” is booming, with residents 50+ set to make up a third of the workforce by 2030 and support 1.7 million jobs. From Columbia’s Aidar Health to national leader Aledade, the state’s life sciences, cyber, and workforce strengths are powering healthier aging. Read More >
On the Calendar
A few of the upcoming events, conferences, and networking opportunities across the BioHealth Capital Region’s life sciences ecosystem that you don’t want to miss.
NIH SBIR/STTR Workshop & Writing Clinic
Tuesday, July 21-Wednesday, July 22 • 9 AM – 1 PM EDT• Richmond, VA
Hosted by Virginia Innovation Partnership Corporation | Register Now >
HealthX – Baltimore (Healthcare Careers)
Wednesday, July 29 • 7 – 10 PM EDT • Baltimore, MD
Hosted by HealthX | Register Now >
WIB-Capital Region: Summer Social
Wednesday, July 29 • 5:30 – 7:30 PM EDT • Gaithersburg, MD
Hosted by Women in Bio | Register Now >
Did we miss something!? Drop us a line →
Stay connected to BioHealth Capital Region life sciences.
🔍 Explore companies → · 💼 Browse jobs → · 📅 See events → · 📰 Read more →
Get the BioHealth Capital Region Roundup every Friday.
The week’s most important life sciences news from BioHealth Capital Region— delivered to your inbox.
